Qurient Co., Ltd. (KOSDAQ:115180)

South Korea · Delayed Price · Currency is KRW

32,250

-1,450 (-4.30%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medicine Wholesale and Retail	9.17B	9.03B	7.88B	4.69B	-
Medicine Wholesale and Retail Growth	1.51%	14.66%	68.10%	-	-
Medicine Research and Development	11.54M	-	591.72M	200.00M	-
Medicine Research and Development Growth	-	-	195.86%	-	-
Total	9.18B	9.03B	8.47B	4.89B	-
Total Growth	1.64%	6.65%	73.33%	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	9.17B	9.03B	8.47B	4.89B	-
South Korea Growth	1.51%	6.65%	73.33%	-	-
Overseas \|	11.54M	-	-	-	-
Total	9.18B	9.03B	8.47B	4.89B	-
Total Growth	1.64%	6.65%	73.33%	-	-

Source: S&P Global Market Intelligence.